GH Research Statistics
NASDAQ: GHRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
21.06-0.46 (-2.14%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 21.04 -0.09%
GH Research by the numbers
GH Research has a market capitalization of $1.45 billion based on 68.64M shares outstanding. With trailing EPS of $-0.99, GH Research is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.0% below its 50-day average and 0.2% below its 200-day average.
Average daily trading volume is 296.90K shares, or about $6.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GHRS valuation vs. peer median
| Metric | GHRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.45B | $1.45B | -1% |
| Avg. volume | 296.90K | 838.55K | -65% |
Peer median across 8 companies: KRSA, RARE, RAPP, TYRA, AAPG, NKTR, SNDX, INVA.
Valuation
- Market cap
- $1.45B
- EPS (TTM)
- $-0.99
- Shares outstanding
- 68.64M
Price and trading
- Previous close
- 21.52
- Open
- 21.39
- Day range
- 21.00 – 22.17
- 52-week range
- 12.04 – 31.44
- 52-week change
- +60.89%
- Beta
- —
- Volume
- 304.64K
- Average volume
- 296.90K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.45B
- Forward Pe
- -11.38
- Eps
- -0.99
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.44
- Week52 Low
- 12.04
- Avg Volume
- 296.90K
- Shares Outstanding
- 68.64M
- Ma50
- 27.36
- Ma200
- 21.10
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -33.01%
- Pct From52w Low
- 74.92%